tiprankstipranks
Alibaba Health Information Technology (MX:241N)
OTHER OTC:241N
Mexico Market
241N
Alibaba Health Information Technology
RESEARCH TOOLSreports

Alibaba Health Information Technology (241N) Stock Forecast & Price Target

― Followers
See the Price Targets and Ratings of:

241N Analyst Ratings

Moderate Buy
5Ratings
Moderate Buy
3 Buy
1 Hold
1 Sell
Based on 5 analysts giving stock ratings to
Alibaba
Health Information Technology
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

241N Stock 12 Month Forecast

Average Price Target

$11.20
Based on 5 Wall Street analysts offering 12 month price targets for Alibaba Health Information Technology in the last 3 months. The average price target is $11.20 with a high forecast of $14.49 and a low forecast of $9.36. The average price target represents a ― change from the last price of ―.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"8":"$8","59":"$59","20.75":"$20.8","33.5":"$33.5","46.25":"$46.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":14.491848865000001,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$14.49</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":11.20108441504,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$11.20</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":9.363963882000002,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$9.36</span>\n  </div></div>","useHTML":true}}],"tickPositions":[8,20.75,33.5,46.25,59],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,58.93,55.511680681923075,52.09336136384616,48.67504204576923,45.256722727692306,41.83840340961538,38.42008409153846,35.00176477346154,31.583445455384616,28.165126137307695,24.74680681923077,21.328487501153845,17.910168183076927,{"y":14.491848865000001,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,58.93,55.258544955003075,51.587089910006156,47.91563486500923,44.244179820012306,40.57272477501539,36.90126973001846,33.22981468502154,29.558359640024616,25.886904595027694,22.21544955003077,18.543994505033844,14.872539460036926,{"y":11.20108441504,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,58.93,55.11722799092308,51.304455981846154,47.49168397276923,43.67891196369231,39.866139954615385,36.05336794553846,32.24059593646154,28.427823927384615,24.615051918307692,20.80227990923077,16.989507900153846,13.176735891076923,{"y":9.363963882000002,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":58.93,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":58.93,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":58.93,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":58.93,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":58.93,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":58.93,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":58.93,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":58.93,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":58.93,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":58.93,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":58.93,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":58.93,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":58.93,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$14.49Average Price Target$11.20Lowest Price Target$9.36
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Jefferies Analyst forecast on MX:241N
Cui Cui
Jefferies
Jefferies
$11.82
Buy
―
Reiterated
05/19/26
Jefferies Reaffirms Their Buy Rating on Alibaba Health Information Technology (ALBHF)
Goldman Sachs Analyst forecast on MX:241N
Lincoln Kong
Goldman Sachs
Goldman Sachs
$10.7→$9.36
Hold
―
Reiterated
05/19/26
Goldman Sachs Remains a Hold on Alibaba Health Information Technology (ALBHF)
Huatai Securities Analyst forecast on MX:241N
Unknown Analyst
Huatai Securities
Not Ranked
Huatai Securities
$12.62→$10.97
Buy
―
Reiterated
05/18/26
Huatai Securities Remains a Buy on Alibaba Health Information Technology (ALBHF)
CICC Analyst forecast on MX:241N
Unknown Analyst
CICC
Not Ranked
CICC
$14.49
Buy
―
Reiterated
05/16/26
CICC Remains a Buy on Alibaba Health Information Technology (ALBHF)
Morgan Stanley Analyst forecast on MX:241N
Alexis Yan
Morgan Stanley
Morgan Stanley
$9.36
Sell
―
Reiterated
05/15/26
Morgan Stanley’s Alexis Yan Reiterates Sell on Alibaba Health Amid Weak Earnings Momentum and High Upfront Investment Costs
Bank of America Securities Analyst forecast on MX:241N
Unknown Analyst
Bank of America Securities
Not Ranked
Bank of America Securities
$13.38
Buy
―
Reiterated
04/14/26
Bank of America Securities Reaffirms Their Buy Rating on Alibaba Health Information Technology (ALBHF)
UOB Kay Hian Analyst forecast on MX:241N
Unknown Analyst
UOB Kay Hian
Not Ranked
UOB Kay Hian
$13.38
Buy
―
Reiterated
04/14/26
Alibaba Health Information Technology (ALBHF) Gets a Buy from UOB Kay Hian
GF Securities Analyst forecast on MX:241N
Unknown Analyst
GF Securities
Not Ranked
GF Securities
$16.48→$14.02
Buy
―
Reiterated
04/09/26
GF Securities Sticks to Their Buy Rating for Alibaba Health Information Technology (ALBHF)
CLSA Analyst forecast on MX:241N
Unknown Analyst
CLSA
Not Ranked
CLSA
$11.82
Buy
―
Reiterated
04/08/26
CLSA Reaffirms Their Buy Rating on Alibaba Health Information Technology (ALBHF)
UBS Analyst forecast on MX:241N
Unknown Analyst
UBS
Not Ranked
UBS
$9.14
Sell
―
Reiterated
04/07/26
UBS Remains a Sell on Alibaba Health Information Technology (ALBHF)
HSBC Analyst forecast on MX:241N
Unknown Analyst
HSBC
Not Ranked
HSBC
$14.49
Hold
―
Reiterated
02/09/26
Alibaba Health Information Technology (ALBHF) Gets a Hold from HSBC
Citi Analyst forecast on MX:241N
Unknown Analyst
Citi
Not Ranked
Citi
$20.07
Buy
―
Reiterated
02/05/26
Citi Sticks to Its Buy Rating for Alibaba Health Information Technology (ALBHF)
Citic Securities Analyst forecast on MX:241N
Unknown Analyst
Citic Securities
Not Ranked
Citic Securities
$26.98
Buy
―
Reiterated
01/15/26
Guotai Haitong Analyst forecast on MX:241N
Unknown Analyst
Guotai Haitong
Not Ranked
Guotai Haitong
$12.69
Buy
―
Reiterated
12/03/25
Alibaba Health Information Technology (ALBHF) Gets a Buy from Guotai Haitong
J.P. Morgan Analyst forecast on MX:241N
Alex Yao
J.P. Morgan
J.P. Morgan
$11.15→$14.49
Hold
―
Reiterated
09/17/25
Alibaba Health Information Technology (ALBHF) Receives a Hold from J.P. Morgan
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Jefferies Analyst forecast on MX:241N
Cui Cui
Jefferies
Jefferies
$11.82
Buy
―
Reiterated
05/19/26
Jefferies Reaffirms Their Buy Rating on Alibaba Health Information Technology (ALBHF)
Goldman Sachs Analyst forecast on MX:241N
Lincoln Kong
Goldman Sachs
Goldman Sachs
$10.7→$9.36
Hold
―
Reiterated
05/19/26
Goldman Sachs Remains a Hold on Alibaba Health Information Technology (ALBHF)
Huatai Securities Analyst forecast on MX:241N
Unknown Analyst
Huatai Securities
Not Ranked
Huatai Securities
$12.62→$10.97
Buy
―
Reiterated
05/18/26
Huatai Securities Remains a Buy on Alibaba Health Information Technology (ALBHF)
CICC Analyst forecast on MX:241N
Unknown Analyst
CICC
Not Ranked
CICC
$14.49
Buy
―
Reiterated
05/16/26
CICC Remains a Buy on Alibaba Health Information Technology (ALBHF)
Morgan Stanley Analyst forecast on MX:241N
Alexis Yan
Morgan Stanley
Morgan Stanley
$9.36
Sell
―
Reiterated
05/15/26
Morgan Stanley’s Alexis Yan Reiterates Sell on Alibaba Health Amid Weak Earnings Momentum and High Upfront Investment Costs
Bank of America Securities Analyst forecast on MX:241N
Unknown Analyst
Bank of America Securities
Not Ranked
Bank of America Securities
$13.38
Buy
―
Reiterated
04/14/26
Bank of America Securities Reaffirms Their Buy Rating on Alibaba Health Information Technology (ALBHF)
UOB Kay Hian Analyst forecast on MX:241N
Unknown Analyst
UOB Kay Hian
Not Ranked
UOB Kay Hian
$13.38
Buy
―
Reiterated
04/14/26
Alibaba Health Information Technology (ALBHF) Gets a Buy from UOB Kay Hian
GF Securities Analyst forecast on MX:241N
Unknown Analyst
GF Securities
Not Ranked
GF Securities
$16.48→$14.02
Buy
―
Reiterated
04/09/26
GF Securities Sticks to Their Buy Rating for Alibaba Health Information Technology (ALBHF)
CLSA Analyst forecast on MX:241N
Unknown Analyst
CLSA
Not Ranked
CLSA
$11.82
Buy
―
Reiterated
04/08/26
CLSA Reaffirms Their Buy Rating on Alibaba Health Information Technology (ALBHF)
UBS Analyst forecast on MX:241N
Unknown Analyst
UBS
Not Ranked
UBS
$9.14
Sell
―
Reiterated
04/07/26
UBS Remains a Sell on Alibaba Health Information Technology (ALBHF)
HSBC Analyst forecast on MX:241N
Unknown Analyst
HSBC
Not Ranked
HSBC
$14.49
Hold
―
Reiterated
02/09/26
Alibaba Health Information Technology (ALBHF) Gets a Hold from HSBC
Citi Analyst forecast on MX:241N
Unknown Analyst
Citi
Not Ranked
Citi
$20.07
Buy
―
Reiterated
02/05/26
Citi Sticks to Its Buy Rating for Alibaba Health Information Technology (ALBHF)
Citic Securities Analyst forecast on MX:241N
Unknown Analyst
Citic Securities
Not Ranked
Citic Securities
$26.98
Buy
―
Reiterated
01/15/26
Guotai Haitong Analyst forecast on MX:241N
Unknown Analyst
Guotai Haitong
Not Ranked
Guotai Haitong
$12.69
Buy
―
Reiterated
12/03/25
Alibaba Health Information Technology (ALBHF) Gets a Buy from Guotai Haitong
J.P. Morgan Analyst forecast on MX:241N
Alex Yao
J.P. Morgan
J.P. Morgan
$11.15→$14.49
Hold
―
Reiterated
09/17/25
Alibaba Health Information Technology (ALBHF) Receives a Hold from J.P. Morgan
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AORTArtivion
ENOVEnovis
GKOSGlaukos
IFRXInflaRx
BKDBrookdale Senior Living
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Alibaba Health Information Technology

3 Months
Alexis YanMorgan Stanley
Success Rate
3/3 ratings generated profit
100%
Average Return
+11.50%
Copying Alexis Yan's trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +11.50% per trade.
1 Year
Alexis YanMorgan Stanley
Success Rate
3/3 ratings generated profit
100%
Average Return
+33.53%
Copying Alexis Yan's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +33.53% per trade.
2 Years
Alexis YanMorgan Stanley
Success Rate
3/3 ratings generated profit
100%
Average Return
+33.53%
Copying Alexis Yan's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +33.53% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

241N Analyst Recommendation Trends

Rating
Mar 26
Apr 26
May 26
Jun 26
Jul 26
Strong Buy
1
0
1
1
1
Buy
2
7
7
7
2
Hold
1
2
2
2
1
Sell
0
1
2
2
1
Strong Sell
0
0
0
0
0
total
4
10
12
12
5
In the current month, 241N has received 3 Buy Ratings, 1 Hold Ratings, and 1 Sell Ratings. 241N average Analyst price target in the past 3 months is 11.20.
Each month's total comprises the sum of three months' worth of ratings.

241N Financial Forecast

No data currently available

241N Earnings Forecast

Currently, no earnings data available.
Currently, no earnings data available.
No data currently available

241N Sales Forecast

Currently, no sales data available.
Currently, no sales data available.

241N Stock Forecast FAQ

What is MX:241N’s average 12-month price target, according to analysts?
Based on analyst ratings, Alibaba Health Information Technology’s 12-month average price target is 11.20.
    What is MX:241N’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for MX:241N, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Alibaba Health Information Technology a Buy, Sell or Hold?
        Alibaba Health Information Technology has a consensus rating of Moderate Buy, which is based on 3 buy ratings, 1 hold ratings and 1 sell ratings.
          What is Alibaba Health Information Technology’s share price target?
          The average share price target for Alibaba Health Information Technology is 11.20. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is $14.49 ,and the lowest forecast is $9.36. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about Alibaba Health Information Technology?
            Alibaba Health Information Technology’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 5 Wall Streets Analysts.
              How can I buy shares of Alibaba Health Information Technology?
              To buy shares of MX:241N, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.